Cardiovascular disease is the leading cause of death in women, and stress-related psychiatric disorders are considered cardiovascular risk factors in their own right. Hormonal contraceptives, which are used by around 9 million women in the USA, have a heterogeneous cardiovascular effect profile. A retrospective cohort study published in JAMA Network Open in January 2026 is the first to systematically investigate how post-traumatic stress disorder (PTSD), depression and anxiety disorders influence the association between combined hormonal contraception and serious cardiovascular events and deep vein thrombosis.
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- Cardiology
Minimally invasive – the quiet triumph of modern heart surgery
- Schizophrenia in the early-onset stage
Which antipsychotic should be used for treatment-naive patients?
- Diarrhea in children
The problem of parental expectations
- From symptom to diagnosis
Multilocular cystic renal cell carcinoma (MCRCC)
- Shaping the Future with LLM & Co.
AI in Everyday Clinical Practice: Friend or Foe?
- Ulcerative colitis: current evidence on anti-inflammatory therapies
Remission induction and maintenance with biologics and JAK-i
- Bronchiectasis